iSpecimen (ISPC) Accumulated Expenses (2020 - 2026)

iSpecimen's Accumulated Expenses history runs 7 years deep, the most recent figure standing at $643503.0 for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 21.36% year-over-year to $643503.0; the TTM figure through Mar 2026 stood at $643503.0 (down 21.36% YoY), while the FY2025 annual figure was $619242.0, down 47.02% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $643503.0, up from $619242.0 in the prior quarter.
• The five-year high for Accumulated Expenses was $1.7 million in Q1 2024, with the low at $7778.0 in Q2 2022.
• The 5-year median for Accumulated Expenses is $908312.0 (2023), against an average of $918267.1.
• Peak annual rise in Accumulated Expenses reached 18649.09% in 2022, while the deepest fall reached 99.59% in 2022.
• iSpecimen's Accumulated Expenses stood at $1.5 million in 2022, then gained by 0.61% to $1.5 million in 2023, then fell by 24.13% to $1.2 million in 2024, then tumbled by 47.02% to $619242.0 in 2025, then grew by 3.92% to $643503.0 in 2026.
• Business Quant data shows ISPC's Accumulated Expenses at $643503.0 in Q1 2026, $619242.0 in Q4 2025, and $716878.0 in Q3 2025.